JAPAN TOBACCO INC. FY2026 Q2 Earnings Report

Quick View

Executive Summary

The key takeaway for Q2 of the fiscal year ending December 2026 was the acceleration of revenue and profit growth, driven by improved pricing and product mix in the Tobacco Business and favorable foreign exchange movements, resulting in an upward revision to the full-year forecast. Revenue was ¥19,860.7B (¥16,867.9B in the year-ago period, +17.7%), while Operating Income was ¥6,449.4B (¥5,001.3B, +29.0%), with the profit growth rate exceeding the revenue growth rate. Net Income was ¥4,331.8B (+34.5%), of which Net Income attributable to owners of the parent was ¥4,318.3B (+35.0%). The Operating Income margin improved by +2.8pt year on year to 32.5%, and progress toward the full-year Operating Income forecast of ¥10,080B was 64.0%, substantially ahead of the 50% half-year benchmark.

Factors Affecting Results

【Revenue】Revenue of ¥19,860.7B (+17.7%) was driven by higher revenue from the Tobacco Business, which accounted for 95.9% of the composition and generated ¥19,055.9B (+18.4%). In addition to price revisions and mix improvement, increased volumes of RRP (reduced-risk products), including Ploom, and favorable foreign exchange movements contributed to growth. Revenue from the Processed Foods Business increased modestly to ¥792.4B (+3.2%), supported by price revisions in the frozen-food and shelf-stable businesses.

【Profit and Loss】Operating Income of ¥6,449.4B (+29.0%) grew faster than revenue, reflecting operating leverage. The gross margin was 58.9% (57.6% in the year-ago period, +1.3pt), while the SG&A expense ratio was 27.1% (28.8% in the year-ago period, -1.6pt). Profit Before Tax was ¥6,060.0B (+32.4%). Although the effective tax rate increased to 28.5% from 26.6% in the year-ago period, the growth in Profit Before Tax more than offset the increase, resulting in Net Income growth of +34.5% (+35.0% for the portion attributable to owners of the parent). In addition, impairment losses amounted to ¥251.8B in the year-ago period, compared with only ¥10.4B in the current period, acting as a one-time factor that amplified profit growth. Overall, the company achieved higher revenue and profits, with price-led operating leverage driving earnings growth.

Segment Analysis

The core business is the Tobacco Business, which generated revenue of ¥19,055.9B (95.9% of the total, +18.4%) and Operating Income of ¥6,829.0B (+25.3%), with a profit margin of 35.8%, making it the central contributor to company-wide profits. The Processed Foods Business generated revenue of ¥792.4B (+3.2%) and Operating Income of ¥40.7B (+58.5%), with a profit margin of 5.1%. Although its profit growth rate was high due to the effects of price revisions, its contribution in absolute profit terms was limited. Other segments generated revenue of ¥12.4B (-1.7%) and recorded Operating Income of -¥252.7B, reflecting the burden of company-wide expenses and other costs. The gap in profit margins between the segments is substantial (35.8% for Tobacco versus 5.1% for Processed Foods), and the primary driver of performance fluctuations was the pricing and mix effect in the Tobacco Business.

Key Financial Metrics

Profitability: ROE 9.8% (7.8% in the year-ago period, +2.0pt), Operating Income margin 32.5% (29.7% in the year-ago period, +2.8pt)
Cash flow quality: Operating CF / Net Income 0.77x (cash generation has not kept pace with Net Income growth year on year, remaining below 1.0x), FCF ¥2,729.1B
Financial soundness: Equity Ratio 50.7% (48.5% in the year-ago period, +2.2pt), Current Ratio approximately 2.04x (current assets ¥38,531.2B / estimated current liabilities ¥18,848.4B)

Cash Flow Analysis

Operating CF was ¥3,313.3B, a substantial increase of +97.9% year on year, but stood at only 0.77x Net Income. In terms of working capital, an increase in trade receivables (-¥1,005.6B), a decrease in trade payables (-¥829.7B), and higher corporate income tax payments (-¥1,356.7B) were negative factors. Investing CF was -¥584.2B, primarily due to capital expenditures of ¥532.3B. Financing CF was -¥2,782.4B, mainly reflecting dividend payments of ¥2,307.2B, while share repurchases were minimal at ¥8.6B. FCF (Operating CF plus Investing CF) was ¥2,729.1B, nearly sufficient to cover dividend payments. Cash generation is assessed as “standard to requiring monitoring,” as increased working capital has slowed cash conversion relative to earnings growth.

Quality of Earnings

As the company applies IFRS, there is no concept of Ordinary Income; therefore, Profit Before Tax of ¥6,060.0B is compared with Net Income of ¥4,331.8B (¥4,318.3B attributable to owners of the parent). The difference between the two is primarily attributable to income taxes of ¥1,728.2B (an effective tax rate of 28.5%, up from 26.6% in the year-ago period), and no significant divergence due to temporary extraordinary gains or losses is evident. Financial income of ¥386.4B was offset by financial expenses of ¥775.8B, resulting in a net cost of approximately ¥389.4B (approximately 2.0% of revenue), which was more than absorbed by the increase in Operating Income. Impairment losses recorded in the year-ago period amounted to ¥251.8B, compared with ¥10.4B in the current period, representing a temporary comparative factor that should be considered when assessing the current period’s profit growth rate. Operating CF was below Net Income, confirming a delay in cash conversion attributable to increased working capital from an accrual perspective.

Earnings Forecast and Guidance

Progress toward the full-year forecasts of revenue of ¥38,850B and Operating Income of ¥10,080B was 51.1% for revenue, 64.0% for Operating Income, and 67.0% for Net Income attributable to owners of the parent (against the forecast of ¥6,440B). Operating Income and Net Income are therefore progressing 14–17pt ahead of the standard H1 benchmark of 50%, indicating an accelerated pace. The full-year forecast has already been revised upward, primarily due to pricing effects in the Tobacco Business exceeding expectations and improving foreign exchange conditions, with the full-year foreign exchange impact revised from an initially projected -¥90B to an expected +¥470B. The annual dividend forecast has also been revised to ¥272, including the interim dividend of ¥136, representing a ¥30 increase.

Shareholder Returns

An interim dividend of ¥136 was recorded, and the company forecasts a full-year dividend of ¥272, an increase of ¥30 from the previous fiscal year. The Payout Ratio is 75.2% based on the company’s disclosure, calculated using adjusted Net Income of ¥6,420B after adjustments related to litigation settlement payments. Share repurchases were small at ¥8.6B, making dividends the primary form of shareholder returns. Even including share repurchases, the impact on total shareholder returns is limited, and the Total Return Ratio remains effectively close to the Payout Ratio.

Catalysts

【Short Term】Progress on price revisions in the second half, trends in market share expansion for RRP products such as Ploom, the impact of accounting adjustments in hyperinflationary countries, and changes in foreign exchange trends will affect quarterly performance.

【Long Term】Trends in tobacco regulations and tax tightening in each country, developments in smoking-related litigation, responses to declining Combustibles demand, and the results of strategic investment in RRP will affect the earnings structure over the medium to long term.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (food_beverage)

Profitability and Returns

The company’s Operating Income margin and Net Income margin are considered to be at high levels within the industry.

Growth and Capital Efficiency

Revenue growth was also in the double digits, indicating solid growth within the industry.

※Source: Compiled by the company

Risk Factors

1. Goodwill dependence: Goodwill of ¥29,867.1B represents 34.4% of total assets and 67.5% of net assets of ¥44,230.5B. Sensitivity to impairment testing in the event of tighter regulations or changes in market conditions is relatively high.

2. Increase in working capital and cash conversion: Operating CF / Net Income remained at 0.77x, with trade receivables increasing by +¥1,130.7B (+17.7%), trade payables decreasing by -¥882.1B (-12.4%), and higher corporate income tax payments (-¥1,356.7B) acting as negative factors. A lag in cash generation relative to earnings growth has been identified.

3. Regulatory and litigation environment: Payments of settlement amounts related to smoking-related litigation, including cases naming Canadian subsidiary JTI-Macdonald Corp. as a defendant, are explicitly identified as adjustment items in calculating the Payout Ratio. This creates a structure in which regulatory and litigation developments affect both earnings and shareholder returns.

Key Earnings Highlights

1. Progress toward the full-year forecasts reached 64.0% for Operating Income and 67.0% for Net Income attributable to owners of the parent, substantially exceeding the standard 50% benchmark. Both the full-year earnings forecast and dividend forecast were revised upward. The fact that price-led profit growth is progressing ahead of the company’s plan is noteworthy.

2. The improvement of +1.3pt in the gross margin and +2.8pt in the Operating Income margin indicates a structural improvement in profitability driven by pricing and mix effects in the Tobacco Business. At the same time, Operating CF / Net Income of 0.77x suggests a gap between earnings growth and cash generation.

3. Goodwill representing 67.5% of net assets is a capital structure based on an M&A-derived growth platform. However, it also relatively reduces the financial cushion in the event of changes in the external environment and will be a monitoring point going forward.

Theoretical Share Price (Reference Value)

This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade). It is not a forecast of the market share price or a recommendation to take any specific investment action.

Sensitivity: ¥2,949–¥3,125 at ±1% for the cost of equity, and ¥3,021–¥3,057 at ±0.1 for ω.

Notes:

• Because Net Income progress toward the full-year forecast (67%) exceeds the standard level (50%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies progressing ahead of their forecasts tend to exceed those forecasts; adjustments may be excessive for businesses with strong seasonality).
• The ratio of goodwill to net assets is high, and the assumptions would change substantially if impairment were recognized.
• Net assets as of the quarter-end are used (there is a timing difference versus the full-year forecast).

(Calculation model: Residual income model / Interest rate reference month: 2026-06 / This figure does not predict or guarantee future share prices)

---

This report is an earnings analysis document automatically generated by AI through integrated analysis of XBRL earnings summary data and PDF earnings presentation materials. It is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.

---End of Report---